Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation

NCT05959824 is registered in ClinicalTrials.gov with Devintec Sagl as lead sponsor.

NCT NCT05959824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05959824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Devintec OR-AT0222 Oral Gel for the Treatment of Canker Sores: A Double Blind, Randomized, Placebo Controlled Clinical Investigation
Lead sponsor
Devintec Sagl
Phase
Not applicable
Overall status
Unknown status
Start date
May 8, 2023
Completion date
September 30, 2023
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent aphthous ulcer